Phaeochromocytoma with normal urinary catecholamines: The potential value of urinary free metadrenalines

Annals of Clinical Biochemistry

Volumn 39, Issue 6, 2002, Pages 557-566

  Davidson, Fraser D ^a  

^a CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; HOMOVANILLIC ACID; METADRENALIN; VANILMANDELIC ACID;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CATECHOLAMINE URINE LEVEL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TUMOR VOLUME; CASE REPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HOMOVANILLIC ACID; HUMANS; MALE; METANEPHRINE; MIDDLE AGED; PHEOCHROMOCYTOMA; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036846387     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456302760413333     Document Type: Article

References (49)

1. Modlin IM, Farndon JR, Shepherd A, Johnston IDA, Kennedy TL, Montgomery DAD, et al. Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results. Br J Surg 1979; 66: 456-65
2. Cohen CD, Dent DM. Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction). Postgrad Med J 1984; 60: 111-5
3. Causon RC, Brown MJ. Catecholamine measurements in phaeochromocytoma: A review. Ann Clin Biochem 1982; 19: 396-404
4. Stenstrom G, Sjogren B, Waldenstrom J. Excretion of adrenaline, noradrenaline, vanilmandelic acid and metanephrines in 64 patients with pheochromocytoma. Acta Med Scand 1983; 214: 145-152
5. Sinclair D, Shenkin A, Lorimer AR. Normal catecholamine production in a patient with a paroxysmally secreting phaeochromocytoma. Ann Clin Biochem 1991; 28: 417-9
6. Neumann HPH, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and Von Hippel-Lindau disease. N Engl J Med 1993; 329: 1531-8
7. Stewart MF, Reed P, Weinkove C, Moriarty KJ, Ralston AJ. Biochemical diagnosis of phaeochromocytoma: Two instructive case reports. J Clin Pathol 1993; 46: 280-2
8. Gerlo EAM, Sevens C. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: Diagnostic value in 19 cases. Clin Chem 1994; 40: 250-6
9. Tormey WP, Fitzgerald FJ. Phaeochromocytomas - A laboratory experience. Ir J Med Sci 1995; 164: 142-5
10. Smythe GA, Drew CM. REPCAT: Desktop expert system for interpreting and validating laboratory data for pheochromocytoma diagnosis with the database application Omnis 7™. Clin Chem 1997; 43: 134-40
11. Rosano TG, Swift TA, Hayes LW. Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma. Clin Chem 1991; 37: 1854-67
12. Reed P, Weinkove C. Diagnosis of phaeochromocytoma: A retrospective analysis of 3 years experience. Proc ACB National Meeting 1998, p 67
13. LaBrosse EH, Mann JD. Presence of metanephrine and normetanephrine in normal human urine. Nature 1960; 185: 40
14. Taniguchi K, Kakimoto Y, Armstrong MD. Quantitative determination of metanephrine and normetanephrine in urine. J Lab Clin Med 1964; 64: 469-84
15. Kobayashi K, Foti A, Dequattro V, Kolloch R, Miano L. A radioenzymatic assay for free and conjugated normetanephrine and octopamine excretion in man. Clin Chim Acta 1980; 107: 163-73
16. Abeling NG, van Gennip AH, Overmars H, Voute PA. Simultaneous determination of catecholamines and metanephrines in urine by HPLC with fluorometric detection. Clin Chim Acta 1984; 137: 211-26
17. Buu NT, Angers M, Chevalier D, Kuchel O. A new method for the simultaneous analysis of free and sulfoconjugated normetanephrine, metanephrine, and 3-methoxytyramine in human urine by HPLC with electrochemical detection. J Lab Clin Med 1984; 104: 425-32
18. Gilmour V. A comparison of the clinical utility of urinary free metadrenalines versus total metadrenalines in the identification of neural crest tumours. Thesis for the degree of MSc. Glasgow Caledonian University, 1995
19. Weinkove C. Adrenaline, noradrenaline and related cornpounds. In: Gowenlock AH, McMurray JR, McLauchlan DM, eds. Varley's Practical Clinical Biochemistry (6th edn). London: Heinemann, 1988: 877-93
20. Eisenhofer G, Keiser H, Friberg P, Mezey E, Huynh T, Hiremagalur B, et al. Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 1998; 83: 2175-85
21. Eisenhofer G, Walther M, Keiser HR, Lenders JWM, Friberg P, Pacak K. Plasma metanephrines: A novel and cost-effective test for pheochromocytoma. Braz J Med Biol Res 2000; 33: 1157-69
22. Eisenhofer G. Free or total metanephrines for diagnosis of pheochromocytoma: What is the difference? Clin Chem 2001; 47: 988-9
23. Green B, Cooper JDH, Turnell DC. An automated method for the analysis of urinary free catecholamines using ASTED and high-pressure liquid chromatography. Ann Clin Biochem 1989; 26: 361-7
24. Weinkove C. Measurement of catecholamines and their metabolites in urine (ACP Broadsheet No 127). J Clin Pathol 1991; 44: 269-75
25. Davidson DF, Fitzpatrick J. A simple, optimised and rapid essay for urinary free catecholamines by HPLC with electrochemical detection. Ann Clin Biochem 1985; 22: 297-303
26. Davidson DF. Urinary free catecholamines - Diagnostic application of an HPLC technique to the investigation of neural crest tumours. Ann Clin Biochem 1987; 24: 494-9
27. Davidson DF. Simultaneous assay for 4-hydroxy-3-methoxymandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid by isocratic HPLC with electrochemical detection. Ann Clin Biochem 1989; 26: 137-43
28. Passing H, Bablok W. A new biochemical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983; 21: 709-20
29. Davidson DF. Urinary catecholamine assay by HPLC: In vitro interference by some drugs. Ann Clin Biochem 1988; 25: 583-4
30. Willemsen JJ, Ross HA, Wolthers BG, Sweep CGJ (Fred), Kema JP. Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. Ann Clin Biochem 2001; 38: 722-30
31. Wassell J, Reed P, Kane J, Weinkove C. Freedom from drug interference in new immunoassays for urinary catecholamines and metanephrines. Clin Chem 1999; 45: 2216-23
32. Crockett DK, Frank EL, Roberts WL. Rapid analysis of metanephrine and normetanephrine in urine by gas chromatography-mass spectrometry. Clin Chem 2002; 48: 332-7
33. Taylor RL, Singh RJ. Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem 2002; 48: 533-9
34. Graham PE, Smythe GA, Edwards GA, Lazarus L. Laboratory diagnosis of phaeochromocytoma: Which analytes should we measure? Ann Clin Biochem 1993; 30: 129-34
35. Ross GA, Newbould EC, Thomas J, Bouloux PMG, Besser GM, Perrett D, et al. Plasma and 24 h-urinary catecholamine concentrations in normal and patient populations. Ann Clin Biochem 1993; 30: 38-44
36. Aron DC. Endocrine incidentalomas. Endocrinol Metab Clin N Am 2000; 29: xiii-xiv
37. Young WF. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin N Am 2000; 29: 159-85
38. Mantero F, Arnaldi G. Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin N Am 2000; 29: 107-25
39. Raber W, Raffesberg W, Kmen E, Hamus A, Niedarle B, Waldhause W, et al. Pheochromocytoma with normal urinary and plasma catecholamines but elevated plasma free metanephrines in a patient with adrenal incidentaloma. Endocrinologist 2000; 10: 65-8
40. Crout JR, Sjoerdsma A. Turnover and metabolism of catecholamines in patients with phaeochromocytoma. J Clin Invest 1964; 43: 94-102
41. Stenstrom G, Waldenstrom J. Positive correlation between excretion of catecholamine metabolites and tumour mass in pheochromocytoma. Acta Med Scand 1985; 217: 73-7
42. Symington T, Goodall AL. Studies in phaeochromocytoma: I. Pathological aspects. Glasgow Med J 1953; 34: 75-96
43. Glenner GG, Crout JR, Roberts WC. A functional carotid body-like tumor secreting levarterenol. Arch Pathol 1962; 73: 230-40
44. Fonseca V, Bouloux PMG. Phaeochromocytoma and paraganglioma. Bailliere's Clin Endocrinol Metab 1993; 7: 509-44
45. Sclafani LM, Woodruff JM, Brennan MF. Extraadrenal retro-peritoneal paragangliomas: Natural history and response to treatment. Surgery 1990; 108: 1124-9
46. Robinson R. The clinical chemistry of phaeochromocytoma. In: Varley H, Gowenlock AH, eds. The Clinical Chemistry of Monoamines. London: Elsevier, 1963: 63-70
47. Tippett PA, West RS, McEwan AJ, Middleton JE, Ackery DM. A comparison of dopamine and homovanillic acid excretion, as prognostic indicators in malignant phaeochromocytoma. Clin Chim Acta 1987; 166: 123-33
48. Christofides JA, Fry DE. Could your laboratory diagnose a chemodectoma? Proc ACB National Meeting 1990, p 121
49. Young WF. Pheochromocytoma and primary aldosteronism: Diagnostic approaches. Endocrinol Metab Clin N Am 1997; 26: 801-27